Ben Tsao

Director, Clinical Scientist

Ben Tsao, PharmD, joins Circle Pharma as our Director, Clinical Scientist. Prior to joining Circle Pharma, Ben held the position of Director, Clinical Scientist at Day One Bio, where he made substantial contributions to a pivotal global Phase 3 study in pediatric neuro-oncology. As a lead clinical scientist, he was instrumental in the development and implementation of study protocols, closely collaborating with cross-functional teams to initiate and manage trial activities. Ben possesses extensive expertise in protocol development, as well as the initiation and maintenance of clinical trials.

Ben embarked on his career in the biopharmaceutical industry as a Clinical Scientist Fellow at Allergan (later acquired by AbbVie), where he contributed to various late-phase neurology and psychiatric development programs. During his tenure at AbbVie, he spearheaded the development of pediatric studies for cariprazine, aimed at addressing pediatric neuropsychiatric disorders. In 2021, Ben transitioned to Day One Biopharmaceutical, where he played a pivotal role in the global Phase 3 tovorafenib, pediatric low-grade glioma program (LOGGIC/FIREFLY-2), advancing treatment options for children facing unmet medical needs.

Ben Tsao holds a Bachelor of Science in Biochemistry from the University of Wisconsin, Madison and earned his Doctorate of Pharmacy from the University of North Carolina, Eshelman School of Pharmacy.

Go to Top